Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12032-014-0473-y
Published Online: 2015-01-21
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Li
Ma, Jie-Tao
Zhang, Shu-Ling
Zou, Hua-Wei
Han, Cheng-Bo
Text and Data Mining valid from 2015-01-21